A neural network model approach to the study of human TAP transporter
暂无分享,去创建一个
Vladimir Brusic | John Zeleznikow | Nikolai Petrovsky | Jürgen Hammer | Peter van Endert | Soizic Daniel | N. Petrovsky | V. Brusic | John Zeleznikow | P. Endert | J. Hammer | S. Daniel
[1] A Sette,et al. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.
[2] J P Cazenave,et al. Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. , 1997, Journal of immunology.
[3] R. Henderson,et al. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. , 1992, Science.
[4] Jacek M. Zurada,et al. Introduction to artificial neural systems , 1992 .
[5] A Sette,et al. The peptide-binding motif for the human transporter associated with antigen processing , 1995, The Journal of experimental medicine.
[6] van Endert Pm. Peptide selection for presentation by HLA class I: A role for the human transporter associated with antigen processing? , 1996 .
[7] Sholom M. Weiss,et al. Computer Systems That Learn , 1990 .
[8] S. Demotz,et al. Peptide-MHC complexes assembled following multiple pathways: an opportunity for the design of vaccines and therapeutic molecules. , 1997, Human immunology.
[9] S Uebel,et al. Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[10] H. Rammensee,et al. Peptides naturally presented by MHC class I molecules. , 1993, Annual review of immunology.
[11] J A Swets,et al. Measuring the accuracy of diagnostic systems. , 1988, Science.
[12] D J Moss,et al. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies , 1996, Journal of virology.
[13] Vladimir Brusic,et al. Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network , 1998, Bioinform..
[14] Vladimir Brusic,et al. MHCPEP, a database of MHC-binding peptides: update 1996 , 1997, Nucleic Acids Res..
[15] J A Koziol,et al. Prediction of binding to MHC class I molecules. , 1995, Journal of immunological methods.
[16] Karsten M. DeckerCSCS,et al. Technology Overview: a Report on Data Mining , 1995 .
[17] J. Neefjes,et al. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling , 1994, The Journal of experimental medicine.
[18] Victor Ciesielski,et al. Application of Genetic Search in Derivation of Matrix Models of Peptide Binding to MHC Molecules , 1997, ISMB.
[19] J. Yewdell,et al. Trimming of antigenic peptides in an early secretory compartment , 1994, The Journal of experimental medicine.
[20] Eric O Long,et al. T cell recognition of an HLA-A2-restricted epitope derived from a cleaved signal sequence , 1994, The Journal of experimental medicine.
[21] Robert DeMars,et al. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter , 1991, Nature.
[22] K. Smith,et al. Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells. , 1996, Journal of immunology.
[23] R W Chesnut,et al. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. , 1997, The Journal of clinical investigation.
[24] R. Tampé,et al. A sequential model for peptide binding and transport by the transporters associated with antigen processing. , 1994, Immunity.
[25] Geoffrey E. Hinton,et al. Learning representations by back-propagating errors , 1986, Nature.
[26] P. Cresswell,et al. Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.
[27] C. Janeway,et al. A tale of two T cells. , 1998, Immunity.
[28] K. Rock,et al. Dissociation of β 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface , 1991, Cell.
[29] M Nijenhuis,et al. Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing. , 1996, Journal of immunology.
[30] J. Neefjes,et al. Peptide selection by MHC-encoded TAP transporters. , 1994, Current opinion in immunology.
[31] J. Yewdell,et al. Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.
[32] F. Sinigaglia,et al. HLA class II peptide binding specificity and autoimmunity. , 1997, Advances in immunology.
[33] D. Wiley,et al. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. , 1998, Immunity.
[34] J. Neefjes,et al. Peptide size selection by the major histocompatibility complex-encoded peptide transporter , 1994, The Journal of experimental medicine.
[35] Günter J. Hämmerling,et al. Selectivity of MHC-encoded peptide transporters from human, mouse and rat , 1994, Nature.
[36] Ronald N. Germain,et al. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.